期刊文献+

D-二聚体/FDP比值在急性与陈旧性脑梗死诊断中的意义 被引量:4

The significance of D-dimer/FDP ratio in distinguish acute and outmoded cerebral infarction
下载PDF
导出
摘要 目的研究急性与陈旧性脑梗死时患者血浆凝血、纤溶活性的变化,探讨D-二聚体/FDP比值在急性与陈旧性脑梗死时的应用价值。方法比较40例急性脑死塞患者与40例陈旧性脑梗死患者血浆凝血、纤溶活性。检测血浆中的纤维蛋白原(Fbg)、D-二聚体(D-dimer)、纤维蛋白(原)降解产物(FDP)三个参数。对三个参数分别进行组合分析,评价不同组合在鉴别急性与陈旧性脑梗死时的应用价值。结果急性脑梗死组血浆D-二聚体/FDP比值明显高于陈旧性脑梗死组(P<0.05);而单独Fbg、FDP比较两组差别无显著性(P>0.05);两组单独D-dimer结果均与正常参考值有差别(P<0.05),但两组相比较,D-dimer值差别无显著性(P>0.05)。结论急性脑梗死的发生存在血液高凝状态大于纤溶状态,D-二聚体/FDP比值可以作为诊断急性与陈旧性脑梗死的快速简便实验室指标。 Objective To study the alteration of plasma coagulation and fibrinolation in acute and outmoded cerebral infarction patients, Discuss the value of D-dimer/FDP ratio in the distinguish diagnosis of acute and outmoded cerebral infarction. Methods To compare 40 acute cerebral infarction patients and 40 outmoded cerebral infarction Patients of coagulation and fibrinolytic activityctivities. To examine plasma Fbg, D-dimer and FDP and study the vary combination of them. Results D-dimer/FDP ratio in acute cerebral infarction group was significantly higher than that in outmoded cerebral infarction group( P 〈 0.05). The isolate levels of Fbg and FDP in acute and outmoded cerebral infarction groups have no signifacately changes ( P 〉 0.05 ), both are higher than normal range ( P 〈 0.05), But D-dimer and FDP levels have no signifacately changes between acute and outmoded cerebral infarction groups( P 〉 0.05). Conclusion It is higher coagulated activity than fibrinolytic activity when acute cerebral infarction Occurs, D-dimer/FDP ratio may be use as an rapid and simple distinguish factor in acute cerebral infarction recurrence.
出处 《中国实验诊断学》 北大核心 2009年第4期504-506,共3页 Chinese Journal of Laboratory Diagnosis
关键词 急性脑梗死 D-二聚体 纤溶功能 acute cerebral infarction D-dimer fibrinolytic function
  • 相关文献

参考文献9

  • 1Mettinger KL, Egberg N. A study of hemostasis in ischemnic cere2brovascular disease Ⅲ.Abnormalities in vascular plasminogen activa2tors. Anacute cerebral infaretionetivators ando22antiplasmin [ J ]. Thromb Res, 1982,26:
  • 2史晓红 韩仲岩 等.脑血栓患者血浆t-PA、PAI活性的研究[J].中华神经精神科杂志,1992,25(5):260-260.
  • 3中华医学会.脑血管疾病诊断和分类诊断要点.中华神经精神科杂志,1996,29(5):376-376.
  • 4Matsumori A, Takano H, Obata JE, et al. Circulating hepatocyte growth factor as a diagnostic marker of thrombus formation in patients with cerebral infarction[J]. Circ J,2002,66(2) :216.
  • 5Tardy B, Tardy-Poncet B, Viallon A. D-dimer levels in patients with suspected acute cerebral venous thrombosis[J] .Am J Med,2002,113(3) : 238.
  • 6Lupu F, Bergonzell GE, Helm DA, et al. Localication and production ofplasminogen activator inhibitor21 in human healthy and atheroscleroticarteries [ J]. Arterioscler Thromb, 1993,13 :1090.
  • 7Altes A, Abellan MT, Mateo J, et al. Hemostatic disturbances in acuteischemic strokes: a study of 86 patients[ J ]. Acta Haematol, 1995,94:10.
  • 8Heinrich J, Sehonfeld R. Association of eoagulation, fibrinolysis and a-cute phase with atheroselerosis in coronary and peripheral arteries and these arteries supplying the brain [ J ]. Thromb Haemost, 1995,371.
  • 9王建中,蒋栋,吴振茹,袁家颖,王淑娟.三种血浆D-二聚体检测方法在血栓性疾病诊断中的应用[J].中华医学检验杂志,1997,20(3):169-171. 被引量:59

二级参考文献1

  • 1Qi G,Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao,1991年,13卷,313页

共引文献74

同被引文献25

  • 1刘成玉,罗春丽.临床检验基础[M].5版.北京:人民卫生出版社.2012:92.
  • 2SEANU AM.Genetic basis and pathophysiologieal implications of high plasma Lp(a)levels[J].J Intern Med,1992,231 (6):679-683.
  • 3中国合格评定国家认可委员会.CNAS-CL02:2012医学实验室质量和能力认可准则[Z].2013-11~22.
  • 4Clinical and Laboratory Standards Institute. CLSI H21 - A5 collec- tion, transport, and processing of blood specimens for testing plas- ma- based coagulation assays; "approved guideline- fifth edition [ S]. Wayne: PA, 2008.
  • 5Clinical and Laboratory Standards Institute. CLSI EP15 - A User demonstration of performance for precision and accuracy ; approved guideline[ S]. Wayne: PA, 2001.
  • 6Clinical and Laboratory Standards Institute. CLSI EP6 - P2 Evalua- tion of linearity of quantitative analytical methods [ S ]. Wayne: PA, 2002.
  • 7Clinical and Laboratory Standards Institute. CLSI C28 - A2 How to define and determine reference intervals in the clinical laboratory [S]. Wayne: PA, 2000.
  • 8Clinical and Laboratory Standards Institute. CLSI EP7 -A2 Inter- ference testing in clinical chemistry [ S ]. Wayne : PA 2000.
  • 9Clinical and Laboratory Standards Institute. CLSI EP9 - A2 Method comparision and bias estimation using patient samples approved guideline[ S]. Wayne: PA, 2002.
  • 10钟海英,周贞学.检测血浆D-二聚体、FDP、TNT对心肌梗死病人的临床意义[J].中国实验诊断学,2010,14(4):577-579. 被引量:19

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部